Summary of Classification and Labelling
Notified classification and labelling
General Information
638-809-1 |
5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one |
146939-27-7 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(other:Damage to...)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
38 |
|
View details
|
STOT RE 2 |
H373
(Damage to organ...)
|
H373
|
STOT RE 2 |
H373
(Central Nervous...)
|
H373
(Central Nervous...)
|
|
GHS08 Wng
|
|
|
|
|
29 |
|
View details
|
STOT SE 3 |
H336
(other:Affected ...)
|
H336
|
|
GHS07 Wng
|
|
|
|
|
1 |
|
View details
|
STOT SE 3 |
H336
(Affected organs)
|
H336
|
Number of Aggregated Notifications: 3